AstraZeneca
AZN
AZN
962 hedge funds and large institutions have $28.4B invested in AstraZeneca in 2022 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 380 increasing their positions, 316 reducing their positions, and 112 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
18% less capital invested
Capital invested by funds: $34.8B → $28.4B (-$6.43B)
29% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 112
38% less funds holding in top 10
Funds holding in top 10: 24 → 15 (-9)
Holders
962
Holding in Top 10
15
Calls
$337M
Puts
$378M
Top Buyers
| 1 | +$266M | |
| 2 | +$217M | |
| 3 | +$183M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$175M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$156M |
Top Sellers
| 1 | -$682M | |
| 2 | -$578M | |
| 3 | -$241M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$188M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$188M |